Enterra Medical, Inc. – Trademark Portfolio
Entity Type: 03
Enterra Medical, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 3 are pending. Notable registered marks include ENTERRA, ENTERRA MEDICAL, and ENTERRA RELIASTIM. The owner is based in St. Louis Park, MN.
5353 Wayzata Boulevard, Suite 400
St. Louis Park, MN 55416
Showing of trademarks Trademarks
Trademark Classifications
Enterra Medical, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Enterra Medical, Inc. have?
Enterra Medical, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending.
What trademark classes does Enterra Medical, Inc. file in?
Enterra Medical, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Enterra Medical, Inc.'s most well-known trademarks?
Enterra Medical, Inc.'s registered trademark portfolio includes well-known marks such as ENTERRA, ENTERRA MEDICAL, and ENTERRA RELIASTIM. These are among 4 currently registered trademarks in the portfolio.
What is Enterra Medical, Inc.'s trademark registration success rate?
Enterra Medical, Inc. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 3 applications are pending review.